Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Current Oncology Reports

Issue 9/2015

Content (4 Articles)

Lymphomas (PA Hamlin, Section Editor)

Epigenetics and Lymphoma: Can We Use Epigenetics to Prime or Reset Chemoresistant Lymphoma Programs?

Jennifer K. Lue, Jennifer E. Amengual, Owen A. O’Connor

Lymphomas (PA Hamlin, Section Editor)

High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma

Oscar B. Lahoud, Craig S. Sauter, Paul A. Hamlin, Parastoo Bahrami Dahi

Lymphomas (PA Hamlin, Section Editor)

Development and Integration of Antibody–Drug Conjugate in Non-Hodgkin Lymphoma

Amitkumar Mehta, Andres Forero-Torres

Integrative Care (C Lammersfeld, Section Editor)

Is There a Role for Homeopathy in Cancer Care? Questions and Challenges

Moshe Frenkel

Aug 15
Issue: 8/2015
Oct 15
Issue: 10/2015

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits